Magali Cucchiarini is a Group Leader and Professor at the Center of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany. Her major research interests include the generation of novel cell-, gene-, and tissue engineered-based compounds to treat orthopaedic disorders of the cartilage, meniscus, and tendons/ligaments, with a focus on using the clinically relevant recombinant adeno-associated viral (rAAV) gene therapy vectors. She graduated from the University of Nice-Sophia Antipolis, Nice, France (Biochemistry and Pharmacology) and received her PhD Thesis with summa cum laude from this University (Virology and Molecular Biology). Before joining the Saarland University, she was a senior post-doctoral fellow at Harvard Medical School, Boston, USA and worked before at the Department of Internal Medicine, University Hospital Inselsspital, Bern, Switzerland. She is the current Chair of the Ethics Committee of the Osteoarthritis Research Society International (OARSI) and serves as a member of the International Committee, Musculo-Skeletal Gene & Cell Therapy Committee, and Stem Cell Committee of the American Society of Gene & Cell Therapy (ASGCT), and of the Basic Science Committee of the European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA).